Alzheimer’s disease
Lexeo Therapeutics Slashes IPO Price to Secure $100M Funding
Anika Sharma
Lexeo Therapeutics has revealed its intention to generate substantial capital through a Nasdaq listing, despite having recently scaled back its ...
A UK initiative will test an EEG gadget for the identification of Alzheimer’s
SG Tylor
Source – Cumulus Neuroscience Digital health company Cumulus Neuroscience has joined forces with two UK universities to advance the development ...
Eisai and Biogen Embark on Full Launch of Leqembi Following Alzheimer’s Approval
SG Tylor
Source – Eisai On July 6, 2023, Eisai and Biogen received full approval from the FDA for their Alzheimer’s disease ...
